HematoLogics, Inc. is a privately owned laboratory with a focus on medicine and scientific discovery. We have an international reputation for our study of myelodysplasia, MRD detection, and the integration of technologies to detect and monitor treatment of hematopoietic diseases. Our approaches are validated through international collaborations and clinical trials. Our experience ensures these innovative techniques support a service oriented hematopathology referral group.